Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent pneumatic compression vs enoxaparin prophylaxis after colorectal cancer surgery
TCTR20230914001Completed
- Sponsor
- Chulabhorn Royal Academy
- Start
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of enoxaparin in venous thromboembolism (VTE) and colorectal cancer (CRC) (2 arms), sponsored by Chulabhorn Royal Academy. Started Feb 2023; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)colorectal cancer (CRC)
Beyond the preview
Go deeper on TCTR20230914001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230914001.